|
Arm, I do not subscribe to any conspiracy theories. Barclays paid money for warrants exercisable well above the present price. I attribute this event to an analyst without an imagination. We have one analyst that is valuing the company based on a per patent modelo. We have others using the revenue/net earnings model. The truth is that the valuation of solid IPR companies has changed since Nortel and an analyst should take this into account when undertaking a new report. It is my belief that an analyst can report anything so long as his/her method is clearly explained within the four corners of the report. One of my deceased friends told me years ago to be careful what I wished for as I screamed about lack of analyst coverage. I know he got a good chuckle as he watched me kick a trashcan into submission yesterday morning. I heard the trash guys laughing this morning as they hauled it off.
MO
zzfan
|